Your Shopping Cart Is Empty
Continue Shopping
Latest Publications Upcoming Publications Company Profiles The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Moreover, increasing awareness of anti-inflammatory biologics and favorable government initiatives in the Asia-Pacific region are expected to drive the market during the analysis period. Factors, such as side effects of anti-inflammatory drugs and uncertain patent legislations, i.e., compulsory licensing in India would continue to impede the market growth.
1.1 Company Overview
1.2 Company Snapshot
1.3 Operating Business Segment
1.4 Business Performance
1.5 Key Strategic moves and Development
TABLE 1. PFIZER INC SNAPSHOT
FIG. 1. PFIZER FINANCIAL REVENUES BY BUSINESS SEGMENTS (2014)
FIG. 2. PFIZER FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 3. PFIZER FINANCIAL REVENUES BY YEAR ($MILLION)
FIG. 4. PFIZER SWOT ANALYSIS & STRATEGIC CONCLUSIONS
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers
PDF Format 